BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12705632)

  • 21. Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice.
    Jerry DJ; Butel JS; Donehower LA; Paulson EJ; Cochran C; Wiseman RW; Medina D
    Mol Carcinog; 1994 Mar; 9(3):175-83. PubMed ID: 8142019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.
    Simanainen U; Gao YR; Walters KA; Watson G; Desai R; Jimenez M; Handelsman DJ
    Horm Cancer; 2012 Jun; 3(3):113-24. PubMed ID: 22370991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
    Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression.
    Aldaz CM; Liao QY; Paladugu A; Rehm S; Wang H
    Mol Carcinog; 1996 Nov; 17(3):126-33. PubMed ID: 8944072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of modeling effects of two different 7, 12-dimethylbenz[a] anthracene induced breast cancer models in tree shrew].
    Mao AY; Chen MJ; Yang C; Ou C; Ye XQ; Qin QH; Mo M; Wei CY
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):346-350. PubMed ID: 31137167
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of the oncogenes mil and ras abolishes the in vivo differentiation of mammary epithelial cells.
    Günzburg WH; Salmons B; Schlaeffli A; Moritz-Legrand S; Jones W; Sarkar NH; Ullrich R
    Carcinogenesis; 1988 Oct; 9(10):1849-56. PubMed ID: 3048764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
    Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
    Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.
    Unni E; Kittrell FS; Singh U; Sinha R
    Breast Cancer Res; 2004; 6(5):R586-92. PubMed ID: 15318939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
    Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
    Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency.
    Feng F; Rittling SR
    Breast Cancer Res Treat; 2000 Sep; 63(1):71-9. PubMed ID: 11079161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability.
    Ma Z; Kim YM; Howard EW; Feng X; Kosanke SD; Yang S; Jiang Y; Parris AB; Cao X; Li S; Yang X
    Oncol Rep; 2018 Sep; 40(3):1632-1640. PubMed ID: 30015966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
    Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancer.
    Stewart MK; Bechberger JF; Welch I; Naus CC; Laird DW
    Oncotarget; 2015 Nov; 6(35):37185-99. PubMed ID: 26439696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells.
    Tu Q; Zhang J; Fix A; Brewer E; Li YP; Zhang ZY; Chen J
    J Cell Physiol; 2009 Jan; 218(1):135-45. PubMed ID: 18756497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    Aprelikova O; Tomlinson CC; Hoenerhoff M; Hixon JA; Durum SK; Qiu TH; He S; Burkett S; Liu ZY; Swanson SM; Green JE
    PLoS One; 2016; 11(5):e0155262. PubMed ID: 27171183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
    Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.